Cargando…

Sex Differences in Psychostimulant Abuse: Implications for Estrogen Receptors and Histone Deacetylases

Substance abuse is a chronic pathological disorder that negatively affects many health and neurological processes. A growing body of literature has revealed gender differences in substance use. Compared to men, women display distinct drug-use phenotypes accompanied by recovery and rehabilitation dis...

Descripción completa

Detalles Bibliográficos
Autor principal:	Torres, Oscar V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9140379/ https://www.ncbi.nlm.nih.gov/pubmed/35627277 http://dx.doi.org/10.3390/genes13050892

Ejemplares similares

Psychostimulants and opioids differentially influence the epigenetic modification of histone acetyltransferase and histone deacetylase in astrocytes
por: Doke, Mayur, et al.
Publicado: (2021)

Influence of psychostimulants and opioids on epigenetic modification of class III histone deacetylase (HDAC)-sirtuins in glial cells
por: Sivalingam, Kalaiselvi, et al.
Publicado: (2021)

Pedunculopontine arousal system physiology—Effects of psychostimulant abuse
por: Urbano, Francisco J., et al.
Publicado: (2015)

Estrogen regulates histone deacetylases to prevent cardiac hypertrophy
por: Pedram, Ali, et al.
Publicado: (2013)

ZNF366 is an estrogen receptor corepressor that acts through CtBP and histone deacetylases
por: Lopez-Garcia, Jorge, et al.
Publicado: (2006)

Histone deacetylase inhibitors: clinical implications for hematological malignancies
por: Tambaro, Francesco Paolo, et al.
Publicado: (2010)

Psychostimulant Drugs and Neuroplasticity
por: Fernandez-Espejo, Emilio, et al.
Publicado: (2011)

Histone Deacetylases: Molecular Mechanisms and Therapeutic Implications for Muscular Dystrophies
por: Sandonà, Martina, et al.
Publicado: (2023)

Beyond Histone and Deacetylase: An Overview of Cytoplasmic Histone Deacetylases and Their Nonhistone Substrates
por: Yao, Ya-Li, et al.
Publicado: (2011)

Histone Deacetylases and Histone Deacetylase Inhibitors in Neuroblastoma
por: Phimmachanh, Monica, et al.
Publicado: (2020)

Locomotor and discriminative stimulus effects of three benzofuran compounds in comparison to abused psychostimulants
por: Hill, Rebecca D., et al.
Publicado: (2023)

Butyrate Histone Deacetylase Inhibitors
por: Steliou, Kosta, et al.
Publicado: (2012)

The Role of Adenosine Receptors in Psychostimulant Addiction
por: Ballesteros-Yáñez, Inmaculada, et al.
Publicado: (2018)

Histone Deacetylases and Histone Deacetylase Inhibitors: Molecular Mechanisms of Action in Various Cancers
por: Sanaei, Masumeh, et al.
Publicado: (2019)

Binge eating and psychostimulant addiction
por: Blanco-Gandia, M Carmen, et al.
Publicado: (2021)

Histone deacetylases in viral infections
por: Herbein, Georges, et al.
Publicado: (2010)

Histone deacetylase signaling in cardioprotection
por: Lehmann, Lorenz H., et al.
Publicado: (2013)

Histone deacetylase 6 in cancer
por: Li, Ting, et al.
Publicado: (2018)

Efficacy of Histone Deacetylase and Estrogen Receptor Inhibition in Breast Cancer Cells Due to Concerted down Regulation of Akt
por: Thomas, Scott, et al.
Publicado: (2013)

Expression of calcium pumps is differentially regulated by histone deacetylase inhibitors and estrogen receptor alpha in breast cancer cells
por: Varga, Karolina, et al.
Publicado: (2018)

Histone deacetylase inhibitors enhance estrogen receptor beta expression and augment agonist-mediated tumor suppression in glioblastoma
por: Pratap, Uday P, et al.
Publicado: (2021)

Ghrelin and ghrelin receptor modulation of psychostimulant action
por: Wellman, Paul J., et al.
Publicado: (2013)

Are There Prevalent Sex Differences in Psychostimulant Use Disorder? A Focus on the Potential Therapeutic Efficacy of Atypical Dopamine Uptake Inhibitors
por: Hersey, Melinda, et al.
Publicado: (2023)

Targeting Histone Deacetylases for Cancer Therapy: From Molecular Mechanisms to Clinical Implications
por: Li, Zhiming, et al.
Publicado: (2014)

Histone Deacetylase Inhibitor-Induced Autophagy in Tumor Cells: Implications for p53
por: Mrakovcic, Maria, et al.
Publicado: (2017)

The Use of Drosophila to Understand Psychostimulant Responses
por: Philyaw, Travis James, et al.
Publicado: (2022)

Dysfunction of the Neurovascular Unit by Psychostimulant Drugs
por: Vo, Tam Thuy Lu, et al.
Publicado: (2023)

The Therapeutic Potential of Amphetamine-like Psychostimulants
por: Pires, Bruno, et al.
Publicado: (2023)

The Role of Histone Deacetylase 3 Complex in Nuclear Hormone Receptor Action
por: Ishii, Sumiyasu
Publicado: (2021)

Clinical Toxicities of Histone Deacetylase Inhibitors
por: Subramanian, Srividya, et al.
Publicado: (2010)

Targeting histone deacetylases for the treatment of disease
por: Lawless, M W, et al.
Publicado: (2009)

Acetylation and Histone Deacetylase Inhibitors in Cancer
por: Kortenhorst, Madeleine S. Q., et al.
Publicado: (2006)

Histone deacetylases as targets for antitrypanosomal drugs
por: Zuma, Aline A, et al.
Publicado: (2018)

Histone Deacetylase Inhibitors as Anticancer Drugs
por: Eckschlager, Tomas, et al.
Publicado: (2017)

The application of histone deacetylases inhibitors in glioblastoma
por: Chen, Rui, et al.
Publicado: (2020)

Histone Deacetylases and Their Inhibitors in Cancer Epigenetics
por: Hassell, Kelly N.
Publicado: (2019)

The Role of Histone Acetyltransferases and Histone Deacetylases in Photoreceptor Differentiation and Degeneration
por: Zhao, Meng, et al.
Publicado: (2020)

Histone acetylation and the role of histone deacetylases in normal cyclic endometrium
por: Gujral, Palak, et al.
Publicado: (2020)

Drug Overdose Deaths Involving Cocaine and Psychostimulants with Abuse Potential — United States, 2003–2017
por: Kariisa, Mbabazi, et al.
Publicado: (2019)

Regulation of Immune Responses by Histone Deacetylase Inhibitors
por: Licciardi, Paul V., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_oi8575aq9og8o30l45uaiintq0